TD Waterhouse Canada Inc. - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 31 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
TD Waterhouse Canada Inc. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,420
-13.7%
6,0000.0%0.00%
Q2 2023$10,920
-17.3%
6,0000.0%0.00%
Q1 2023$13,200
+61.8%
6,0000.0%0.00%
Q4 2022$8,160
+29.5%
6,0000.0%0.00%
Q3 2022$6,300
-2.8%
6,0000.0%0.00%
Q2 2022$6,480
+3.8%
6,0000.0%0.00%
Q1 2022$6,240
+8.3%
6,0000.0%0.00%
Q4 2021$5,7606,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$2,513,0000.04%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$27,0000.02%
MEITAV INVESTMENT HOUSE LTD 244,332$256,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$139,0000.00%
IHT Wealth Management, LLC 22,000$23,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BANK OF AMERICA CORP /DE/ 3,027$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DAVENPORT & Co LLC 22,000$23,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders